# Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma Based on Whole-Slide Digital Pathological Images and Deep Learning

> **NCT07417800** · NA · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 1000 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)
- Artificial Intelligent
- Adjuvant Chemoradiotherapy
- TACE
- Lenvatinib
- Liver Surgery

## Interventions

- **PROCEDURE:** TACE
- **PROCEDURE:** TACE combined with Lenvatinib

## Key facts

- **NCT ID:** NCT07417800
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2029-01-01
- **Final completion:** 2029-12-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07417800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07417800, "Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma Based on Whole-Slide Digital Pathological Images and Deep Learning". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07417800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
